De Novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient. Case Reports Hepatol 2022;2022:8409269
Date
01/03/2023Pubmed ID
36590671Pubmed Central ID
PMC9800079DOI
10.1155/2022/8409269Abstract
Liver test abnormalities have been described during severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection causing coronavirus disease 2019. Most of them consist of elevation of the aminotransferases that resolve once the infection subsides. There are several reports of autoimmune hepatitis developing after vaccination against COVID-19 and one case of autoimmune hepatitis following COVID-19 infection. We present a patient that was not vaccinated against COVID-19 and developed resistant de novo autoimmune hepatitis following COVID-19 infection requiring aggressive immunosuppression.
Author List
Durazo FA, Kristbaum K, Miller J, Saeian K, Selim M, Hong JCAuthors
Francisco A. Durazo MD Professor in the Medicine department at Medical College of WisconsinKia Saeian MD Professor in the Medicine department at Medical College of Wisconsin